[Pharmacologic characteristics of pyrroxan].
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000317:Adrenergic alpha-Antagonists; D000661:Amphetamine / Q000037:antagonists & inhibitors; D000818:Animals; D001115:Arecoline / Q000037:antagonists & inhibitors; D001339:Autonomic Fibers, Preganglionic / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects; D002346:Carotid Sinus / Q000187:drug effects; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D002746:Chlorpromazine / Q000494:pharmacology; D003214:Conditioning, Classical / Q000187:drug effects; D003250:Constriction; D003326:Coronary Circulation / Q000187:drug effects; D004147:Dioxins / Q000494:pharmacology*; D004594:Electrophysiology; D004837:Epinephrine / Q000037:antagonists & inhibitors; D006220:Haloperidol / Q000494:pharmacology; D006634:Histamine H1 Antagonists; D007031:Hypothalamus / Q000187:drug effects; D007422:Intestines / Q000187:drug effects; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D011760:Pyrrolidinones / Q000494:pharmacology*; D011817:Rabbits; D014655:Vascular Resistance / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D004147:Dioxins; D006634:Histamine H1 Antagonists; D011760:Pyrrolidinones; D001115:Arecoline; D000661:Amphetamine; D006220:Haloperidol; D000109:Acetylcholine; D002746:Chlorpromazine; D004837:Epinephrine
Farmakologicheskaia kharakteristika pirroksana.